Equillium Inc
For the period ended Dec 31, 2023. Filed Mar 25, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 25, 2024
EQ$1.46-3.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Operations and Comprehensive Loss
(In thousands, except share and per share data)
| Year EndedDecember 31, | Year EndedDecember 31, | |
|---|---|---|
| 2023 | 2022 | |
| Revenue | $36,084 | $15,759 |
| Operating expenses: | ||
| Research and development | 37,039 | 37,547 |
| Acquired in-process research and development | - | 23,049 |
| General and administrative | 13,567 | 17,239 |
| Total operating expenses | 50,606 | 77,835 |
| Loss from operations | (14,522) | (62,076) |
| Other income (expense), net: | ||
| Interest expense | (491) | (1,053) |
| Interest income | 2,334 | 420 |
| Other (expense) income, net | (76) | 281 |
| Total other income (expense), net | 1,767 | (352) |
| Net loss before income tax expense | (12,755) | (62,428) |
| Income tax expense | 580 | - |
| Net loss | $(13,335) | $(62,428) |
| Other comprehensive income, net: | ||
| Unrealized gain (loss) on available-for-sale securities, net | 108 | (38) |
| Foreign currency translation (loss) gain | (44) | 252 |
| Total other comprehensive income, net | 64 | 214 |
| Comprehensive loss | $(13,271) | $(62,214) |
| Net loss per share, basic and diluted | $(0.38) | $(1.85) |
| Weighted-average number of common shares outstanding, basic and diluted | 34,726,384 | 33,727,945 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.